| Preview | Issue Date | Title | Author(s) |
| 2018 | A patient-derived explant (PDE) model of hormone-dependent cancer | Centenera, M.M.; Hickey, T.E.; Jindal, S.; Ryan, N.K.; Ravindranathan, P.; Mohammed, H.; Robinson, J.L.; Schiewer, M.J.; Ma, S.; Kapur, P.; Sutherland, P.D.; Hoffmann, C.E.; Roehrborn, C.G.; Gomella, L.G.; Carroll, J.S.; Birrell, S.N.; Knudsen, K.E.; Raj, G.V.; Butler, L.M.; Tilley, W.D. |
| 2020 | Antimicrobial action and reversal of resistance in MRSA by difluorobenzamide derivatives targeted at FtsZ | Chai, W.C.; Whittall, J.J.; Song, D.; Polyak, S.W.; Ogunniyi, A.D.; Wang, Y.; Bi, F.; Ma, S.; Semple, S.J.; Venter, H. |
| 2022 | Cinnamaldehyde derivatives act as antimicrobial agents against Acinetobacter baumannii through the inhibition of cell division | Chai, W.C.; Whittall, J.J.; Polyak, S.W.; Foo, K.; Li, X.; Dutschke, C.J.; Ogunniyi, A.D.; Ma, S.; Sykes, M.J.; Semple, S.J.; Venter, H. |
| 2020 | Design and structural optimization of novel 2H-benzo[h]chromene derivatives that target AcrB and reverse bacterial multidrug resistance | Wang, Y.; Alenazy, R.; Gu, X.; Polyak, S.W.; Zhang, P.; Sykes, M.J.; Zhang, N.; Venter, H.; Ma, S. |
| 2020 | Design and synthesis of novel 4-substituted quinazoline-2-carboxamide derivatives targeting AcrB to reverse the bacterial multidrug resistance | Gu, X.; Pisoni, L.A.; Wang, Y.; Song, D.; Sykes, M.J.; Qin, Y.; Semple, S.J.; Polyak, S.W.; Venter, H.; Ma, S. |
| 2019 | Design, synthesis and evaluation of a series of 5-methoxy-2,3-naphthalimide derivatives as AcrB inhibitors for the reversal of bacterial resistance | Jin, C.; Alenazy, R.; Wang, Y.; Mowla, R.; Qin, Y.; Tan, J.Q.E.; Modi, N.D.; Gu, X.; Polyak, S.W.; Venter, H.; Ma, S. |
| 2017 | Evaluation of a series of 2-napthamide derivatives as inhibitors of the drug efflux pump AcrB for the reversal of antimicrobial resistance | Wang, Y.; Mowla, R.; Guo, L.; Ogunniyi, A.D.; Rahman, T.; De Barros Lopes, M.A.; Ma, S.; Venter, H. |
| 2005 | Fast global kernel density mode seeking with application to localisation and tracking | Shen, C.; Brooks, M.; Van Den Hengel, A.; Ma, S.; Shum, H.; IEEE International Conference on Computer Vision (10th : 2005 : Beijing, China) |
| 2016 | Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer | Singhal, H.; Greene, M.; Tarulli, G.; Zarnke, A.; Bourgo, R.; Laine, M.; Chang, Y.-F.; Ma, S.; Dembo, A.; Raj, G.; Hickey, T.; Tilley, W.; Greene, G. |
| 2022 | Grapevine recovery after fire and a first look at rapid damage assessment with satellite imagery | Collins, C.; Ritchie, M.; James, A.; O'Brien, P.; Ma, S.; De Bei, R.; Clarke, A.; International Terroir Congress and ClimWine Symposium (terclim) (3 Jul 2022 - 8 Jul 2022 : Bordeaux, France) |
| 2016 | Removal of pertechnetate-related oxyanions from solution using functionalized hierarchical porous frameworks | Banerjee, D.; Elsaidi, S.; Aguila, B.; Li, B.; Kim, D.; Schweiger, M.; Kruger, A.; Doonan, C.; Ma, S.; Thallapally, P. |
| 2020 | Structural optimization of natural product nordihydroguaretic acid to discover novel analogues as AcrB inhibitors | Wang, Y.; Alenzy, R.; Song, D.; Liu, X.; Teng, Y.; Mowla, R.; Ma, Y.; Polyak, S.W.; Venter, H.; Ma, S. |
| 2008 | T Cell Responses to Whole SARS Coronavirus in Humans | Li, C.; Wu, H.; Yan, H.; Ma, S.; Wang, L.; Zhang, M.; Tang, X.; Temperton, N.; Weiss, R.; Brenchley, J.; Douek, D.; Mongkolsapaya, J.; Tran, H.; Lin, C.L.; Screaton, G.; Hou, J.; McMichael, A.; Xu, X. |
| 2022 | Targeting malaria parasites with novel derivatives of azithromycin | Burns, A.L.; Sleebs, B.E.; Gancheva, M.; McLean, K.T.; Siddiqui, G.; Venter, H.; Beeson, J.G.; O’Handley, R.; Creek, D.J.; Ma, S.; Frölich, S.; Goodman, C.D.; McFadden, G.I.; Wilson, D.W. |
